BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
177 hedge funds and large institutions have $1.9B invested in bluebird bio in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 68 increasing their positions, 61 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
5% less funds holding
Funds holding: 187 → 177 (-10)
26% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 31
Holders
177
Holding in Top 10
4
Calls
$22.4M
Puts
$24.8M
Top Buyers
| 1 | +$37.8M | |
| 2 | +$26.7M | |
| 3 | +$21.6M | |
| 4 |
RI
RTW Investments
New York
|
+$16.7M |
| 5 |
DM
Deerfield Management
New York
|
+$14.6M |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$10.9M | |
| 3 | -$8.15M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.58M |
| 5 |
CCI
Columbus Circle Investors
|
-$6.05M |